Prostate cancer (PCa) is genomically driven by dysregulation of transcriptional networks involving the 30 transcriptional factors (TFs) FOXA1, ERG, AR, and HOXB13. However, the role of these specific TFs 31 in the regulation of alternative pre-mRNA splicing (AS), which is a proven therapeutic vulnerability for 32 cancers driven by the TF MYC, is not described. Using transcriptomic datasets from PCa patients, 33
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Introduction 50
Prostate cancer (PCa) is the commonest male gender-specific cancer 1 . Genomic characterisation of 51 primary PCa has uncovered several molecular subtypes [2] [3] [4] , characterised by alterations in genes 52 encoding the transcription factors (TFs) FOXA1, ERG, and AR, which is an existing therapeutic target 53 5 . The gene encoding the AR-interacting TF HOXB13 has been identified as a candidate PCa 54 susceptibility gene 6 . Co-operatively, these TFs reprogram the AR-associated cistrome in prostate 55 tumourigenesis [7] [8] [9] . Additionally, PCa susceptibility loci identified from genome-wide association 56 studies (GWAS) fall within the cistromes of these TFs themselves 10 , thereby demonstrating 57 widespread dysregulation of transcriptional networks in PCa. 58
Results 73
Dysregulated SRP gene expression is associated with FOXA1 in primary human PCa 74 75 We hypothesised that dysregulation of SRP genes and others involved in gene expression processes 76 in PCa is transcriptionally controlled by one or more of the TFs FOXA1, ERG, AR or HOXB13. To 77 test this hypothesis, we utilised published RNA-Seq gene expression data of primary untreated 78 prostate tumours (n=409) included in The Cancer Genome Atlas (TCGA) 2 . Transcriptomes were 79 analysed based on expression levels (i.e. transcript per million reads, TPMs) of FOXA1, ERG, AR 80 and HOXB13 genes ( Fig. 1A ). We included MYC as a positive control as it is implicated in the 81 regulation of SRP expression [20] [21] [22] . Samples were stratified for expression of genes encoding these 82
five TFs with a cut-off of the top 25% of gene expression by TPM defining high expression (HE) and 83 the remainder as Rest ( Fig. 1A and B , and Supplementary Data 1) 23 . 84
To determine the biological processes that are altered upon HE of the TFs, we performed a 85 gene set analysis (GSA) (see Methods). For each TF, we compared the cumulative TPM values of 86 genes in 16 gene sets representing Genetic Information Processing pathways accordingly to the 87 Kyoto Encyclopedia of Genes and Genomes (KEGG) 24 between samples with HE of the TF gene 88
and Rest ( Fig. 1C and Supplementary Fig. 1 ). In doing so, GSA identified associations between 89 expression of all TF genes and six different KEGG pathways, including the SRP gene set (Fig. 1C , 90 Supplementary Table 1 ). To evaluate the impact of altered expression of genes in the six gene sets 91 on PCa disease progression, we performed a survival analysis using Cox proportional hazards (PH) 92 models (see Methods). Of the genes within the six gene sets, we found that dysregulated SRP gene 93 expression showed the strongest association with disease recurrence (HR= 25.5; 95% CI=14.6-44.5) 94 ( Fig. 1D and Supplementary Table 2 ). Additionally, using a SRP gene set score to stratify patients 95 (see Methods), we observed a statistically significant difference in time to disease progression 96 between patients with a high score as compared to those with a low score (p-value < 0.0001) ( Fig.  97   1E) , thereby highlighting the importance of SRP genes in the PCa disease phenotype. 98
To determine which of the five TFs may be most important for SRP gene regulation, we 100 employed a linear regression modelling approach (See Methods). We found that the overexpression 101 of FOXA1 gave the best results in terms of determination coefficient (R 2 =0.3, Fig. 1F ) when modelling 102 SRP gene expression using only one TF gene. Increasing the model complexity led to a closer fitting 103 between TF overexpression and SRP gene expression levels, with the five variables giving the highest 104 fitting (R 2 =0.54, Fig. 1F ). We next measured the relative importance of each regressor in the linear 105 model with all five TF genes using the averaging over ordering method 25 (see Methods). We found 106 that FOXA1 expression is the most important regressor contributing to 36% of the fitting of the model 107 ( Fig. 1G ). Collectively, these findings suggest that, among all tested TFs, the expression of FOXA1 108
shows the strongest correlation with the modulation of SRP gene expression in PCa. 109
110
The FOXA1 cistrome includes a subset of actively-transcribed SRP genes 111 112
To identify SRP candidate genes regulated by FOXA1, we performed differential expression analysis 113 using three distinct approaches (see Methods): Firstly, we identified a total of 76 SRP genes that 114 were significantly up-(n=54) or down-(n=22) regulated in samples with FOXA1 HE as compared with 115 Fig. 2A ). Secondly, we determined which 116 of the 76 SRP genes had enrichment for the five TF binding sites within their promoter regions and 117 gene bodies using the ReMap database 26 ( Fig. 2A ). Finally, we selected sites of active transcription 118 by overlapping TF binding sites with the H3K27ac and H3K4me3 signatures. FOXA1 binding sites 119 were most enriched within these genes compared to the other transcription factors (Fig. 2B) , with 120 63/76 SRP genes containing FOXA1-binding sites (Supplementary Fig. 2A ). Of the 63 SRP genes 121 with FOXA1 binding sites, the majority (47/63) were up-regulated. These data suggest that FOXA1 122 might directly control expression of up-regulated SRP genes in PCa. 123
FOXA1 Rest (Supplementary Data 2 and Supplementary
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The expression and function of FOXA1 and SRP genes are similar in human PCa cell line models 126 127
To characterise human PCa cell line models for downstream validation, we profiled FOXA1 128 expression by qRT-PCR and western blotting in DU145, PC3, LNCaP and VCaP cells ( Fig. 2C and 129 Supplementary Fig. 2B ). We identified the highest level of FOXA1 expression in the AR-and ERG-130 positive VCaP cells, and the lowest level of expression in DU145 cells (Fig. 2D ). FOXA1 has been 131 identified as an essential PCa gene in a RNAi genome-wide loss of function screen 27 , and in this 132 dataset VCaP and DU145 cells harboured the greatest and least dependency (DEMETER scores) on 133 FOXA1, respectively ( Fig. 2E ). To confirm this observation, we used two independent siRNA 134 duplexes ( Supplementary Table 3 ) to deplete VCaP and DU145 cells of FOXA1 protein 135 ( Supplementary Fig. 2C , upper panel). Following FOXA1 depletion, we observed a statistically 136 significant reduction in cell growth in VCaP cells as compared with NSI controls, but no statistically 137 significant change in cell growth in DU145 cells ( Supplementary Fig. 2C , lower panel). 138
We hypothesised that FOXA1-overexpressing VCaP cells may also be dependent on FOXA1-139 associated SRP genes. Of the 47 up-regulated SRP genes with FOXA1-binding sites identified from 140 the TCGA analysis (Supplementary Fig. 2A ), we selected the top 10 ranked SRP genes by TPM and 141 top 10 ranked by fold change of median TPM between FOXA1 HE samples and Rest for further 142 analysis ( Fig. 2E ). Using the RNAi dataset 27 , we ranked these 20 SRP genes by VCaP cell 143 dependency DEMETER score, and selected seven candidate SRP genes with a DEMETER score 144 smaller than -1 for qRT-PCR validation in four different PCa cell lines. We profiled expression of the 145 seven candidate SRP genes in the four PCa cell lines by qRT-PCR and observed the highest levels 146 of expression of SRP genes in FOXA1-overpressing VCaP cells as compared with DU145 cells (Fig. 147 2F and Supplementary Table 4 ). Taken together, our data identify a subset of seven up-regulated 148 and FOXA1-associated SRP genes in primary PCa that phenocopy FOXA1 in PCa cells that over-149 Of the candidate SRP genes, a number were bound by AR and ERG as well as FOXA1 ( Fig. 2E ). 176
Since FOXA1 has been implicated as a pioneer factor 28 and is co-opted by AR 29 and ERG 30 in PCa 177 cells, we hypothesised that the observed FOXA1 regulated SRP gene expression is mediated by AR 178 and ERG. To test this hypothesis, we used siRNA to deplete ERG in the VCaP cells, and AR in VCaP 179
and LNCaP cells ( Supplementary Fig. 3 , left panels). Surprisingly, following siRNA-mediated ERG knockdown, we observed an increase in expression of two out of seven SRP genes by qRT-PCR 181 ( Supplementary Fig. 3A , right panel), which appeared to be due to an increase in FOXA1 protein 182 expression as determined by western blotting ( Supplementary Fig. 3A , left panel). siRNA-mediated 183 AR knockdown in LNCaP and VCaP cells did not significantly impact on FOXA1 protein expression 184 nor SRP gene expression ( Supplementary Fig. 3B and C). Consistent with our findings in silico ( Fig.  185 1), these data confirm that AR and ERG are not as important as FOXA1 in SRP gene regulation in 186
PCa, and suggest that this role may be a novel AR-independent function of FOXA1. 187
188
FOXA1-associated SRP gene dysregulation is persistent in advanced treatment-relapsed PCa 189 190
We sought to determine whether the dysregulation of SRP genes persists in late-stage, metastatic, 191 castration-resistant PCa (CRPCa) which inevitably develops following longstanding androgen 192 deprivation therapy (ADT) 5 , and whether this is associated with expression of FOXA1, ERG, AR, 193 HOXB13 and MYC. We utilised published RNA-Seq gene expression data of CRPCa samples from 194 patients (n=118) included in the Stand Up to Cancer (SU2C) study 31 . As before, transcriptomes were 195 stratified by expression levels (i.e. TPMs) of TFs ( Fig. 4A ) with a cut-off of the top 25% of gene 196 expression by TPM defining HE. We did not detect a statistically significant difference in the levels of 197
FOXA1 expression between the FOXA1 HE tumours in the TCGA and SU2C datasets (two-tailed 198
Wilcoxon rank sum test, Supplementary Fig. 4A ). Next, we repeated the GSA to determine the 199 biological processes that are altered upon HE of TF genes by comparing the cumulative TPM values chromatin conformation 32 . FOXA1 has been described as a pioneer factor 28 for other transcription 217 factors allowing the re-defining of cistromes 7, 30, 33, 34 , including the AR cistrome during prostate 218 tumourigenesis 7, 35 . FOXA1 is one of the most commonly mutated genes in PCa 36, 37 and disease 219 susceptibility loci fall within the FOXA1 cistrome 10 , thereby highlighting its dysregulation in PCa. 220
Little is known of the mechanisms underpinning the transcriptional regulation of genes 221 encoding RNA-binding and other proteins involved in AS 11, 16 , which we term as SRPs. To date, only 222 MYC has been shown to transcriptionally drive expression of SRPs 20-22 , thereby presenting AS as a 223 cancer therapeutic vulnerability for MYC-driven tumours 18, 19 . Here, we show for the first time that 224 FOXA1, but not AR or ERG, regulates a subset of SRP genes that phenocopy the FOXA1 225 dependency of PCa cells, thereby expanding the AR-independent FOXA1 gene regulatory repertoire 226 33, 35 . AR-independent FOXA1-driven transcriptional programmes have been shown to occur via 227 genomic interactions with other transcriptional regulators such as MYBL2 and CREB1 in CRPCa 33 , 228 GATA-3 and the Estrogen Receptor (ER) in breast cancer 38 , and PPARγ in bladder cancer 39 . 229
Additionally, interactions between ER and glucocorticoid receptor (GR) and FOXA1 appear to be 230 dynamic 40 , hence our AR-independent observations may be context-dependent in PCa. 231
Considering the overlapping cistromes for FOXA1 and the ETS-family TF ERG 30 , we were 232 surprised that depletion of ERG and FOXA1 had opposing effects on SRP gene expression. We 233 concluded that this was due to an ERG-driven increase in FOXA1 expression by the ERG siRNA. 234 AR-regulated TMPRSS gene and ERG in ~50% PCa cases 41 . Hence, our findings may highlight 236 differing mechanisms of FOXA1-mediated SRP gene regulation in ERG fusion-positive and -negative 237
PCa. Since loss of the tumour suppressor PTEN appears to be required for widespread co-operative 238 AR and ERG-driven transcriptomic changes 8 , we may have failed to identify ERG-driven SRP gene 239 expression changes in PTEN-proficient VCaP cells. However, our data in PTEN-deficient LNCaP 240 cells suggest that AR does not regulate SRP gene expression in the absence of PTEN. 241
A recent genome-wide screen of PCa cell dependencies 42 identified the heterogeneous 242 nuclear ribonuclear protein (hnRNP) family of SRPs, including the FOXA1-regulated SRP genes 243 HNRNPA1 and HNRNPK, which have been previously implicated in PCa [43] [44] [45] [46] and other malignancies 244 47 . The SRP hnRNPA1 has been shown to regulate expression of the CRPCa-and FOXA1-245 associated AR splice variant AR-V7 43, 44, 46, 48, 49 . Interestingly, we show that FOXA1 can control 246 expression of SF3B1, which is the most-commonly altered SRP gene in PCa 3 and haematological 247 malignancies 50 . Lethality can be induced in cancers with mutations affecting SF3B1 and other SRP 248 genes by therapeutic targeting the SF3b complex of the spliceosome 51 , although the impact in cancers 249 with up-regulated (but wild-type) SF3B1 and other SRP genes is unknown. We also identify the SRP 250 HSPA8, which encodes a heat shock protein (HSP) scaffold in the core spliceosome complex 52 , as 251 a FOXA1-regulated gene that exhibited a high dependency for PCa cells. Therapeutic targeting the 252 HSP family member HSP90 has been shown to harbour anti-tumour activity and also modulate AS in 253 CRPCa 53, 54 . 254
The role of FOXA1 in advanced PCa is still contradictory, with reports of AR-dependent 55 255
and -independent functions 33, 35 . On one hand, FOXA1 protein expression is up-regulated in primary 256 PCa 34,56,57 , metastases and CRPCa 56 , and is associated with metastasis 58 , disease recurrence 257 56, 57, 59 , and survival 34 . However, on the other hand, FOXA1 has also been described as an inhibitor 258 of metastasis 35 and neuroendocrine differentiation 60 , which is associated with a poor prognosis. We 259 were unable to identify a difference in the levels of FOXA1 expression amongst the FOXA1 HE 260 tumours in the TCGA and SU2C datasets, however, we did observe a persistent association between 261 FOXA1 and SRP genes in CRPCa. 262
Our data demonstrate, for the first time in both primary PCa and CRPCa, that FOXA1 is 263 associated with SRP gene expression, the dysregulation of which confers a poor patient prognosis. 264
In a subset of FOXA1 binding and actively-transcribed SRP genes that phenocopy the FOXA1 265 dependency of PCa cells, we confirm FOXA1-regulated SRP gene expression in PCa cell lines. 266
Hence, we speculate that in both primary PCa and CRPCa, targeting SRPs may represent a 267 therapeutic vulnerability for FOXA1-overexpressing PCa in an analogous way to MYC-driven cancers. 268
This would need to be tested in future studies by therapeutic targeting of SRPs or upstream signaling 269 cascades. For each TF t and each gene set i, the cumulative TPM values of genes in i were compared 290 between samples where the t was HE and the remaining ones (Rest) using a two-tailed Wilcoxon 291 rank sum test ( Supplementary Fig. 1A) . The resulting p-values were corrected for multiple tests using 292 the Bonferroni method. To control for false discoveries, Monte Carlo simulation was implemented as 293 previously described 65 . For 10,000 times, we randomly extracted 103 samples (corresponding to the 294 number of samples with HE TF) and the cumulative expression of each gene set was compared with 295 that of the remaining samples. Next, for each gene set, the empirical p-value is measured as the 296 number of times the p-value is smaller than the observed one over the total number of iterations. For each gene set, patients were then stratified on the 75 th percentile of the score distribution, and a 308 univariable Cox PH model was used to generate hazard ratios (HR) between patients with a high 309 score as compared to those with a low score. For the SRP gene set scores, event-time distributions for the time to disease progression were compared using the log-rank test. The PH assumption and 311 influential observations were met. All analyses were performed using the R 'survival' package 66 . 312
313
Linear regression modelling of the SRP gene set 314 SRP gene expression was fitted on the expression of the TFs using a linear regression model. The 315 search for the best subsets of regressor was performed using a branch-and-bound algorithm 67 316 implemented in the regsubsets function in th R 'leaps' package. For models using a different number 317 of variables (i.e. from 1 to 5 TFs) the best model in terms of determination coefficient R 2 was reported. 318
Relative importance of regressors in the linear regression model of five TFs was calculated using the 319 function calc.relimp in the R 'reclaimpo' package 68 . This function divides the determination coefficient 320 R 2 into the contribution of each regressor using the averaging over ordering method 25 . The 321 confidence intervals of the contributions of the regressors were measured using a bootstrap 322 procedure implemented in the function boot.relaimp. For 1,000 iterations the full observation vectors 323
were resampled and the regressor contributions were calculated. 324 325
Selection of highly expressed SRPs 326
SRPs that were highly expressed between FOXA1 HE (n=103 and 30 for TCGA and SU2C, 327 respectively) and Rest (n=306 and 88 for TCGA and SU2C, respectively) were identified comparing 328 the TPM distributions of the two groups with a one-tailed Kolmogorov-Smirnov (KS) test. The resulting 329 p-values were corrected for multiple tests using the Bonferroni method. To control for size differences 330 between the two cohorts, a Monte Carlo procedure was implemented. For 10,000 times, FOXA1 HE 331 and Rest samples were randomly selected and, for each SRP, the TPM distributions were compared 332 using a one-tailed KS test. Next, for each SRP gene, the empirical p-value was measured as the 
Selection of TFs implicated in SRP gene expression 346
Enrichment analysis of TF binding sites within SRP genes was performed using chromatin 347 immunoprecipitation sequencing (ChIP-Seq) data from the ReMap database and annotation tool 69 . 348
Genomic coordinates of SRP genes were extended by 5,000 bp and used as input for the ReMap 349 Table 8 ). Reaction conditions were as 420 follows: 20 s at 50 °C, 10 min at 95 °C, and 40 cycles of 15 s at 95 °C and 1 min at 60 °C. Relative 421 gene expression was determined by the 2 -ΔΔCT method using the geometric mean of two validated 422 endogenous control genes (ACTB and B2M) to ensure the reliability and reproducibility of observed 423 effects. Data shown are from three independent biological experimental replicates with two technical 424 replicates. 425 426
Cell viability assays 427
Cell viability assays were performed using (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium 428 Bromide) (MTT) (L11939.06, Alfa Aesar) according to the manufacturer's instructions. Briefly, 4000-429 10 000 cells were seeded into each well of a 96-well plate and grown to ~20-30% confluence prior to 430 transfection with siRNA. After 72 h, MTT was added to each well to a final concentration of 0.67 431 mg/ml and incubated at 37 o C, 5% CO 2 in a humidified incubator for 2 h. Subsequently, MTT reagent 432 was removed, 100µl dimethyl sulfoxide (DMSO) (10213810, Thermo Fisher Scientific) added to each 433 well and agitated at room temperature for 15 mins. Absorbance was measured at 560nm and 630nm 434 (SpectraMax Plus384 Absorbance Microplate Reader, Molecular Devices), and normalised by 435 subtracting the 630nm value from the 560nm value, and percentage viability calculated as follows: 436
Treatment absorbance ÷ DMSO control absorbance ×100. All siRNA data were normalized to a non-437 silencing control. Results shown are the means ± SEM of at least three independent experiments with 438 at least 3 technical replicates. 439
Statistical analysis for in vitro data 442
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